Cargando…
Adalimumab induced interstitial lung disease
Tumor necrosis factor inhibitors have been implicated in many pulmonary complications. Before starting these class of drugs latent infection as tuberculosis and preexisting lung disease should be excluded. These agents have been linked to pulmonary nodules, pneumonitis, fibrosis, autoimmune reaction...
Autores principales: | Aqsa, Anum, Sharma, Dikshya, Chalhoub, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005541/ https://www.ncbi.nlm.nih.gov/pubmed/32055438 http://dx.doi.org/10.1016/j.rmcr.2020.101012 |
Ejemplares similares
-
Late presentation of lung adenocarcinoma in a stable solitary pulmonary nodule: A case presentation and review of the literature
por: Aqsa, Anum, et al.
Publicado: (2020) -
Adalimumab-induced acute interstitial lung disease in a patient with
rheumatoid arthritis
por: Dias, Olívia Meira, et al.
Publicado: (2014) -
Placental transmogrification of the lung associated with unilateral pleural effusion: A case report with a comprehensive review of the literature
por: Narula, Naureen, et al.
Publicado: (2018) -
Treatment of sarcoid granulomatous interstitial nephritis with adalimumab
por: Gupta, Roopali, et al.
Publicado: (2009) -
Timolol-induced interstitial lung disease
por: Patel, Hetain, et al.
Publicado: (2015)